Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

A new method for identifying causative genes in triple negative breast cancer

FY 2015-16

Summary
Triple Negative Breast Cancer (TNBC) is a type of cancer that affects young women, often under the age of 40. It is very aggressive, has a high recurrence rate, and often spreads to other parts of the body which altogether make it a very deadly disease. Currently, TNBC is difficult to treat and often fatal. Recent genome-wide studies have discovered specific genes that are frequently mutated in TNBC and could therefore potentially be targets for new therapies. However, it is difficult to determine whether these mutations are actually driving the development of tumors or if they are randomly acquired. We will address this problem by creating a method that will enable us to screen these candidate TNBC genes to see if they are involved in TNBC. To do this, we will use viruses to insert DNA constructs into the genome of embryonic mouse tissue which will cause mutations in specific genes. These DNA constructs are maintained even in an adult mouse. In our current study, we will test several different strategies to see which is best at specifically targeting breast tissue and has the highest efficiency of mutating the specific genes of interest. To do so, we will use fluorescent proteins as markers which will allow us to see which cells have received the construct and which have been successfully mutated. Once we have developed this model, in future studies we can use it to specifically mutate genes in the breast tissue of mice to see which mutated genes result in breast tumours. This will enable us to determine the role of different genes in TNBC and ultimately find new drug targets for this devastating disease that affects young women.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
349852
Name
Langille Ellen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A new method for identifying causative genes in triple negative breast cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Crispr Editing; Genome Editing; In-Utero Microinjection; Methodology; Mouse Models; Oncogene; Transgenic Mice; Tripe Negative Breast Cancer; Tumor Suppressor; Viral Vector
Abstract
Triple Negative Breast Cancer (TNBC) is a type of cancer that affects young women, often under the age of 40. It is very aggressive, has a high recurrence rate, and often spreads to other parts of the body which altogether make it a very deadly disease. Currently, TNBC is difficult to treat and often fatal. Recent genome-wide studies have discovered specific genes that are frequently mutated in TNBC and could therefore potentially be targets for new therapies. However, it is difficult to determine whether these mutations are actually driving the development of tumors or if they are randomly acquired. We will address this problem by creating a method that will enable us to screen these candidate TNBC genes to see if they are involved in TNBC. To do this, we will use viruses to insert DNA constructs into the genome of embryonic mouse tissue which will cause mutations in specific genes. These DNA constructs are maintained even in an adult mouse. In our current study, we will test several different strategies to see which is best at specifically targeting breast tissue and has the highest efficiency of mutating the specific genes of interest. To do so, we will use fluorescent proteins as markers which will allow us to see which cells have received the construct and which have been successfully mutated. Once we have developed this model, in future studies we can use it to specifically mutate genes in the breast tissue of mice to see which mutated genes result in breast tumours. This will enable us to determine the role of different genes in TNBC and ultimately find new drug targets for this devastating disease that affects young women.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Langille, Ellen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~